Determination of HCV genotype using two antibody assays and genome typing

Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):666-9. doi: 10.1007/s100960100576.

Abstract

Two serotyping assays for hepatitis C virus (Serotyping 1-6 assay; Murex, UK and RIBA Serotyping SI; Chiron, USA) were compared to a standardized genotyping assay (Inno-LiPA HCV II; Innogenetics, Belgium) using serum samples collected from 126 patients chronically infected with hepatitis C virus. Serotyping was positive in 87% and 80% of the samples tested with Murex and Chiron, respectively, and concordant with genotyping in 93% and 88%, respectively. Sequence analysis of the NS5b region of 15 samples with discrepant typing results confirmed the Inno-LiPA finding in all instances. The Murex enzyme immunoassay serotyping method was less sensitive for identifying genotype 2 (P<0.05). The concordance with genotyping of the RIBA serotyping method was lower for genotype 2 than for the other genotypes (P<0.05).

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Viral / analysis*
  • Chi-Square Distribution
  • DNA, Viral / analysis
  • Genes, Viral / genetics*
  • Genotype
  • Hepacivirus / genetics*
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic / blood
  • Humans
  • Immunoenzyme Techniques
  • Probability
  • Sensitivity and Specificity
  • Serotyping / methods

Substances

  • Antibodies, Viral
  • DNA, Viral